• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

9-Aminocamptothecin Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758119

9-Aminocamptothecin is an inhibitor of topoisomerase I with potent anticancer activity. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
9-Aminocamptothecin, Inhibitor
Full Product Name
9-Aminocamptothecin
Product Synonym Names
9-amino-CPT; 9-amino-2(S)-camptothecin; Aminocamptothecin
Form/Format
Solid. Powder
Purity/Purification
99.82%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
363.40
Solubility
DMSO: 3.33mg/mL (9.16mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C20H17N3O4
SMILES
CC[C@](C(C=C(c1nc2ccc3)N4Cc1cc2c3N)=C(CO1)C4=O)(C1=O)O
CAS Number
91421-43-1
Target & IC50
Topo I
In Vitro
9-Aminocamptothecin inhibits tumor growth at the lowest oral dose (0.35mg/kg/day), whereas higher oral doses (0.75 and 1mg/kg/day) and s.c. administration (4mg/kg/week) causes tumor regression [1]. 9-Aminocamptothecin induces complete remissions in 55% of SCID mice engrafted with human myeloid leukemia. The oral and intravenous routes are equally effective [3].

Product References and Citations for 9-Aminocamptothecin, inhibitor

de Souza PL, et al. 9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancer. Clin Cancer Res. 1997 Feb;3(2):287-94.
de Souza PL, et al. 9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancer. Clin Cancer Res. 1997 Feb;3(2):287-94.
Li ML, et al. Pharmacological determinants of 9-aminocamptothecin cytotoxicity. Clin Cancer Res. 2001 Jan;7(1):168-74.
Li ML, et al. Pharmacological determinants of 9-aminocamptothecin cytotoxicity. Clin Cancer Res. 2001 Jan;7(1):168-74.
Jeha S, et al. Activity of oral and intravenous 9-aminocamptothecin in SCID mice engrafted with human leukemia. Leuk Lymphoma. 1998 Dec;32(1-2):159-64.
Jeha S, et al. Activity of oral and intravenous 9-aminocamptothecin in SCID mice engrafted with human leukemia. Leuk Lymphoma. 1998 Dec;32(1-2):159-64.

Other Notes

Small volumes of 9-Aminocamptothecin, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for 9-Aminocamptothecin purchase

MBS5758119 is an inhibitor targeting 9-Aminocamptothecin.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000